CARDIOPROGRESS
Foundation for the advancement of cardiology

Why L.G.B.T.Q. Adults Are More Vulnerable to Heart Disease Experts say that a leading cause of death often goes overlooked.

Ventricular Changes Seem Worse in Persistent vs Paroxysmal AF The study covered in this summary was published on ResearchSquare.org as a preprint and has not yet been peer reviewed.

No Thrombotic Risk From Higher Lp(a) Levels Contrary to indications from previous studies, there is no association between increased lipoprotein(a) concentrations and the risk for subsequent thrombotic events, suggests a new large-scale analysis. (Milan)

Noninvasive Approach to Revascularization Decisions Shows Promise When deciding on the optimal revascularization strategy for patients with multivessel coronary disease, a noninvasive approach using quantitative flow ratio (QFR) showed substantial agreement with the more invasive classical fractional flow reserve (FFR) approach in a new study.

SAFE-PAD Shows Long-Term Safety of Paclitaxel Devices Patients who have paclitaxel-coated stents and balloons have survival and outcomes comparable to those who have a bare-metal stent or percutaneous transluminal angioplasty, according to updated results from a large study of almost 170,000 Medicare beneficiaries.

ADT for Prostate Cancer: What's the Risk on the Heart? Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.

Genetic Test for Six Chronic Diseases Undergoing Clinical Trial A new type of genetic test known as a polygenic risk score could change the way clinicians detect and treat chronic illnesses. But to be widely used, genomic findings in large populations first need to be translated into valid clinical tests for individual patients. Then physicians need meaningful interpretations of test data to help make clinical decisions about patient care.

Greater Triglyceride-Glucose Index Variability Tied to CV Risk The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed.

Smokers With Heart Disease Could Gain 5 Years by Quitting Smoking cessation appears to be comparable to the use of three targeted drugs in warding off future major cardiovascular events in smokers with atherosclerotic cardiovascular disease (ASCVD), according to a new study.

FDA Approves Fitbit's AFib-Detection Software A popular fitness tracker company has received approval from the Food and Drug Administration for a new software algorithm to detect atrial fibrillation (AFib), Fitbit announced on April 11.

AHA Joins New Cardiovascular Certification Group ABCVM The American Heart Association (AHA) has now formally voted to join several other cardiovascular societies to form a new professional certification board for cardiovascular medicine, to be known as the American Board of Cardiovascular Medicine (ABCVM).

Coronary artery calcium: from risk prediction to treatment allocation and clinical trials Coronary artery calcium (CAC) is a direct measure of an individual’s coronary atherosclerotic burden.

Peripheral arterial disease - indications for intervention: from open surgery to endovascular and hybrid repair Peripheral arterial disease (PAD) is a marker of increased risk of СV mortality and limb loss. Staging of limb ischaemia severity, assessment of patient risk and knowledge of PAD anatomy are essential requirements to improve survival, reduce major cardiovascular events and to treat the ischaemic syndrome.

New Clinical Practice Guideline for the Management of Adult Overweight and Obesity Synopsis summarizes the key recommendations of the guideline regarding management of overweight and obesity, including referral to comprehensive lifestyle interventions that combine behavioral, dietary, and physical activity change, and additional tools of pharmacologic and procedural interventions.

HFA CONFERENCE NEWS June 29 - July 01, 2021, Virtual IV Iron Can Save Costs in HF With Iron Deficiency in Analysis; HF Med Undertreatment Due to Older Age Common, Flouts Evidence; Iron-Clad Benefits of CRT Seen in Reduced-EF Heart Failure; Assays May Guide SGLT2 Inhibitor Use in High CV-Risk Diabetes

"COVID-19 and cardiovascular diseases: main aspects" The report of Igor S. Yavelov MD, PhD, Professor of cardiology CV risk factors and CVD are present in many patients with COVID-19 and their presence is associated with an increased risk of cardiovascular complications with new coronavirus infection.

Young adults who lost and then restored heart health had lower risk of heart attack, stroke A long-term analysis of young adults in Korea found that those with poor heart health had higher rates of cardiovascular disease at a younger age.

EAS Helsinki 2021 Virtual. THE RISE OF CARDIOMETABOLIC DISEASE Not only are we living in a COVID-19 pandemic, but also an accelerating pandemic of cardiometabolic disease, requiring renewed focus. The third plenary session discussed options to address this escalation in cardiometabolic disease.

COVID-19 vaccine benefits still outweigh risks, despite possible rare heart complications. Statement from the American Heart Association/American Stroke Association Late last week, the U.S. Centers for Disease Control and Prevention (CDC) alerted health care professionals that they are monitoring the Vaccine Adverse Events Reporting System (VAERS) and the Vaccine Safety Datalink (VSD) for cases of young adults developing the rare heart-related complication myocarditis, after receiving a COVID-19 vaccine manufactured by Pfizer-BioNTech or Moderna.

Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov. Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N. Mamedov